New York’s average cannabis price dropped from $38.61 to $32.15 as licensed store openings and expanded product selection increased competition. This decline shows the market is maturing — but it also raises new challenges for operators navigating shrinking margins and rising compliance pressure.

A new Oregon study finds that adults living near licensed cannabis stores report less heavy drinking and more marijuana use, especially among Gen Z and Baby Boomers. The findings suggest cannabis access may be replacing alcohol as a preferred wellness or social alternative.

A major edible-fruit brand is launching hemp-derived THC gummies and beverages aimed at wellness consumers seeking alcohol-free relaxation. The move highlights how mainstream companies are entering the cannabis ecosystem amid evolving regulations and rising consumer demand.

Receiverships are often misunderstood in cannabis, but they can provide struggling operators with a path to stability and compliance. Learn how this legal tool can protect licenses, preserve value, and set businesses up for long-term survival.

The FDA has begun actively tracking adverse health events linked to hemp and CBD products. This new reporting process marks a step toward greater federal oversight and signals important changes ahead for operators, investors, and consumers.